Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.

MLA

Atkinson, K., et al. “Oral Administration of Cyclosporin A for Recipients of Allogeneic Marrow Transplants: Implications of Clinical Gut Dysfunction.” British Journal of Haematology, vol. 56, no. 2, Feb. 1984, pp. 223–31. EBSCOhost, https://doi.org/10.1111/j.1365-2141.1984.tb03950.x.

APA

Atkinson, K., Biggs, J. C., Britton, K., Short, R., Mrongovius, R., And, A. C., & Dodds, A. (1984). Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction. British Journal of Haematology, 56(2), 223–231. https://doi.org/10.1111/j.1365-2141.1984.tb03950.x

Chicago

Atkinson, K., J. C. Biggs, K. Britton, R. Short, R. Mrongovius, A. Concannon And, and A. Dodds. 1984. “Oral Administration of Cyclosporin A for Recipients of Allogeneic Marrow Transplants: Implications of Clinical Gut Dysfunction.” British Journal of Haematology 56 (2): 223–31. doi:10.1111/j.1365-2141.1984.tb03950.x.